Skip to main content
. 2021 Jul 15;117(1):181–264. [Article in Portuguese] doi: 10.36660/abc.20210180

Figure 3.2. Recommendations for changing P2Y12 inhibitors in patients after 30 days of acute coronary syndrome. * If ticagrelor to clopidogrel therapy is being de-escalated due to bleeding or an increased risk of bleeding, only a maintenance dose of clopidogrel can be considered. Adapted from Valgimigli et al.451.

Figure 3.2